Glycan binding assays were carried out as described previously [51 (link)] using oligosaccharides representing various HBGA types, well-defined human saliva samples from donors with type O, A, B, and non-secretor (N) blood types, and/or pig gastric mucin (PGM). Briefly, polyacrylamide-oligosaccharides (GlycoTech Inc) at 2 µg/mL, pretreated saliva samples (our lab stocks) at 1:1000 dilution, or type III PGM (Sigma-Aldrich) 5 µg/mL were coated on microtiter plates at 4°C overnight. After blocking with 5% (w/v) non-fat milk, the coated HBGAs were incubated with the wild type or mutant P proteins (10 µg/mL or indicated concentrations) for 60 min at 37°C. The bound P proteins were detected as described previously [21 (link),22 (link)], using an in-house hyperimmune guinea pig serum against huNoV VLPs [51 (link)].
Free full text: Click here